France
# |
Name |
EBITDA Margin |
Reported Date | Stock Price |
Change |
Price (30 days) | Country |
---|---|---|---|---|---|---|---|
1 |
31.68%
|
Dec. 31, 2023 | USD 3.46 | -1.94% |
|
France |
|
2 |
26.06%
|
Dec. 31, 2023 | USD 107.71 | -0.06% |
|
France |
|
3 |
21.22%
|
Dec. 31, 2023 | USD 76.53 | 1.34% |
|
France |
|
4 |
18.79%
|
Dec. 31, 2023 | USD 26.53 | 0.03% |
|
France |
|
5 |
-14.60%
|
Dec. 31, 2023 | USD 2.09 | 3.97% |
|
France |
|
6 |
-37.55%
|
Dec. 31, 2023 | USD 3.46 | 7.58% |
|
France |
|
7 |
-50.59%
|
Dec. 31, 2023 | USD 2.39 | -7.42% |
|
France |
|
8 |
-100.09%
|
Dec. 31, 2023 | USD 3.58 | 3.12% |
|
France |
|
9 |
-135.45%
|
Dec. 31, 2023 | USD 1.42 | 2.06% |
|
France |
|
10 |
-155.83%
|
March 31, 2024 | USD 17.01 | 1.06% |
|
France |
|
11 |
-157.55%
|
Dec. 31, 2023 | USD 0.63 | -3.60% |
|
France |
|
12 |
-556.11%
|
Dec. 31, 2023 | USD 4.22 | -0.94% |
|
France |
|
13 |
-583.86%
|
Dec. 31, 2023 | USD 2.40 | -1.45% |
|
France |
|
14 |
-785.86%
|
Dec. 31, 2023 | USD 6.79 | 2.49% |
|
France |
|
15 |
-900.14%
|
Dec. 31, 2023 | USD 5.82 | 3.14% |
|
France |
|
16 |
-956.80%
|
Dec. 31, 2023 | USD 1.64 | -0.17% |
|
France |
|
17 |
-2,882.64%
|
Dec. 31, 2023 | USD 6.04 | 2.29% |
|
France |
The Vaccines company in France with the highest EBITDA Margin is genOway SA (Paris Stock Exchange: ALGEN.PA) at 31.68%.
The Vaccines company in France with the lowest EBITDA Margin is ABIVAX SA (Paris Stock Exchange: ABVX.PA) at -2,882.64%.
The top 10 Vaccines companies in France by EBITDA Margin are genOway SA, Sanofi, Vetoquinol SA, Eurobio Scientific SA, Innate Pharma S.A., Valneva SE, Aelis Farma SA, Nanobiotix S.A., Valbiotis SA and MedinCell S.A..
The bottom 10 Vaccines companies in France by EBITDA Margin are ABIVAX SA, AB Science S.A., Adocia SA, OSE Immunotherapeutics SA, Inventiva S.A., DBV Technologies S.A., Novacyt S.A., MedinCell S.A., Valbiotis SA and Nanobiotix S.A..